UTI Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹7404 Cr | ₹986 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 01 Jun 2004 | 05 Aug 2005 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 28% |
| Expense Ratio | 1.82 | 2.29 |
| Manager | Sailesh Raj Bhan | Kamal Gada |
| ISIN Code | INF204K01968 | INF789F01695 |
| Exits Load | Exit load of 1% if redeemed within 1 month./365 | Exit load of 1% if redeemed within 30 days./365 |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Month | -4.56% | -3.43% |
| 6 Month | 14.93% | 23.56% |
| 1 Year | 34.98% | 43.83% |
| 3 Year | 18.23% | 19.66% |
| 5 Year | 26.92% | 26.95% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 31.44% | 45.07% |
| 3 Year | 30.78% | 34.39% |
| 5 Year | 25.57% | 26.61% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Year | 17.79% | 10.93% |
| 3 Year | 20.87% | 15.88% |
| 5 Year | 20.18% | 14.02% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Standard Deviation | 14.36% | 14.3% |
| Sharp | 0.68% | 0.62% |
| Beta | 0.91% | 0.94% |
| Alpha | 1.57% | 0.78% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Name | Sailesh Raj Bhan | Kamal Gada |
| Total AUM | ₹96086 Cr | ₹870 Cr |
| Fund Manage | 5 | 1 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 4.4 | 2.21 |
| Large Cap | 45.96 | 33.75 |
| Mid Cap | 27.12 | 31.32 |
| Small Cap | 22.52 | 32.72 |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 4.4 | 0.97 |
| Pharmaceuticals & Biotechnology | 75.86 | - |
| Healthcare Services | 17.38 | - |
| Retailing | 2.36 | - |
| Financial | - | 0.13 |
| Healthcare | - | 97.31 |
| Insurance | - | 1.59 |
Top Comparisons
HDFC Hybrid Debt Fund - Growth Plan
3Y Returns9.64%
HSBC Conservative Hybrid Fund - Regular Growth
3Y Returns8.09%
UTI Large & Mid Cap Fund - Regular Plan - Growth Option
3Y Returns18.88%
Sundaram Large and Midcap Fund Regular Plan - Growth
3Y Returns13.32%
Franklin India Index Fund- NSE Nifty 50 Index Fund - Growth
3Y Returns10.34%
Motilal Oswal Nifty Next 50 Index Fund - Regular plan - Growth
3Y Returns15.53%
HDFC Corporate Bond Fund - Growth Option
3Y Returns6.15%
DSP Corporate Bond Fund - Regular - Growth
3Y Returns5.26%